API Innovation Center @ Cortex Announces New "Re-shoring" Strategy for Critical Drug Ingredients

SourceCISION PR Newswire
Date Published09/21/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name API Innovation Center
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2022
City reshored to:St. Louis
State(s) reshored to:MO
If relevant, work nearshored to:-
Product(s) reshoredCritical Drug Ingredients, treatment of glioblasto
What non-domestic negative factors made offshoring less attractive?Supply chain interruption risk/Natural disaster risk/Political instability
What domestic positive factors made reshoring more attractive?Skilled workforce availability/training, Biden
Government Incentive dollar amount:$1 million grant from Biden's Build Back Better
Find Reshoring Articles